Approval of the protocol for the ode lead pma post-approval study.
Device | I-FACTOR PEPTIDE ENHANCED BONE GRAFT |
Classification Name | Filler, Bone Void, Synthetic Peptide |
Generic Name | Filler, Bone Void, Synthetic Peptide |
Applicant | CERAPEDICS, LLC |
Date Received | 2015-12-03 |
Decision Date | 2016-03-17 |
PMA | P140019 |
Supplement | S001 |
Product Code | NOX |
Advisory Committee | Orthopedic |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | Yes |
Applicant Address | CERAPEDICS, LLC 11025 Dover Street suite 1600 westminster, CO 80021 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P140019 | | Original Filing |
S007 |
2022-10-19 |
30-day Notice |
S006 |
2022-01-19 |
30-day Notice |
S005 |
2021-12-09 |
30-day Notice |
S004 |
2020-06-15 |
Normal 180 Day Track No User Fee |
S003 |
2019-04-17 |
Normal 180 Day Track No User Fee |
S002 |
2016-01-19 |
Normal 180 Day Track |
S001 |
2015-12-03 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices